Jazz Pharmaceuticals (JAZZ) SEC Filings & 10K Form

$113.12
+2.42 (+2.19%)
(As of 05/9/2024 ET)

Recent Jazz Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/07/2024
4:31 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:38 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2024
3:39 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:07 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:49 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:53 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:44 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:48 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:09 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:54 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:58 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:28 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:32 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:34 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:44 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:50 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:52 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:11 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2024
6:14 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/01/2024
2:11 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:46 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:29 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/25/2024
4:01 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
01/19/2024
5:19 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:21 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:23 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:25 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:28 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:33 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:39 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:31 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
6:36 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
12:33 PM
Jazz Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
09/06/2023
4:09 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
09/01/2023
3:39 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/31/2023
5:44 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2023
4:41 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
4:21 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:49 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:51 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:58 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:00 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:02 PM
Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:08 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:47 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:49 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:52 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:56 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:40 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
4:43 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:44 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:45 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
8:55 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:35 PM
Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:40 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:28 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:00 PM
Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:04 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:09 PM
Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:15 PM
Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:19 PM
Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:54 PM
Jazz Pharmaceuticals (Subject)
Sohn Catherine A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:36 PM
Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
5:41 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2023
3:05 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:12 PM
Jazz Pharmaceuticals (Filer)
Form DEF 14A
06/12/2023
3:47 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:12 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
6:15 PM
Jazz Pharmaceuticals (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:16 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
7:24 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
5:01 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2023
7:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
6:38 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
3:08 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:JAZZ) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners